CONRAD   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Arlington VA United States (1986)
Status: No NME R&D (1986)

Organization Overview

First Clinical Trial
2004
NCT00161447
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

CONRAD | CONRAD/EVMS

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 3)

Herpes Simplex (Phase 4)

HIV Infections (Phase 3)

Infections (Phase 3)

Inflammation (Phase 2)

Mucositis (Phase 2)

Rupture (Phase 2)

Vaginitis (Phase 2)

Vitamin D Deficiency (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 47
  • # of Trial APIs: 23